Abstract
Availability and affordability of medicines are crucial to delivery of health services in any community. In many countries, public sector institutions play a significant role in providing health services but when public health facilities lack medicines they risk losing trust of the population. Children and families will go elsewhere or be forced into the private sector where care and medicines are often unaffordable. Child-specific issues complicate the pre-existing challenges of adequate financing, timely procurement and distribution of quality-assured medicines in many low and middle income countries. Progress has been made in recent years with renewed efforts at the global, regional and national level to improve access to paediatric medicines. Effort has been focused to reduce stock-outs and to ensure availability of appropriate dosage forms. Emphasis has also been placed on increasing demand for evidence-based prescribing, supporting quality use by health providers. Further research is needed in critical facets, including preclinical and clinical studies and incentivization of the private sector.
Keywords
- Essential Medicine
- Private Health Facility
- Paediatric Medicine
- Paediatric Formulation
- Essential Medicine List
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Knibbe CA, Krekels EH, van den Anker JN, deJongh J, Santen GW, van Dijk M, et al. Morphine glucuronidation in preterm neonates, infants and children younger than 3 years. Clin Pharmacokinet. 2009;48:371–85. doi:10.2165/00003088-200948060-00003.
Cella M, Knibbe C, Danhof M, Della Pasqua O. What is the right dose for children? Br J Clin Pharmacol. 2010;70:597–603. doi:10.1111/j.1365-2125.2009.03591.x.
Tayman C, Rayyan M, Allegaert K. Neonatal pharmacology: extensive inter-individual variability despite limited size. J Pediatr Pharmacol Ther. 2011;16:170–84. doi:10.5863/1551-6776-16.3.170.
World Health Organization. Antiretroviral therapy for HIV infection in infants and children: towards universal access: recommendations for a public health approach: 2010 revision. Annex E: prescribing information and weight-based dosing of available ARV formulations for infants and children. http://www.who.int/hiv/pub/paediatric/infants2010/en/. Accessed 10 Oct 2014.
Swaminathan S, Rekha B. Pediatric tuberculosis: global overview and challenges. Clin Infect Dis. 2010;50 Suppl 3:S184–94. doi:10.1086/651490.
World Health Organization. Rapid advice: treatment of tuberculosis in children. Geneva: World Health Organization. 2010. http://apps.who.int/iris/bitstream/10665/44444/1/9789241500449_eng.pdf?ua=1. Accessed 10 Oct 2014.
World Health Organization. Global tuberculosis report 2013. http://www.who.int/tb/publications/global_report/en/. Accessed 6 Sept 2014.
UNITAID. Tuberculosis – innovative approaches for an ancient disease: Speeding treatments to end paediatric tuberculosis (STEP-TB). http://www.unitaid.eu/en/what/tb. Accessed 8 Oct 2014.
World Health Organization. Make medicines child size. http://www.who.int/childmedicines/en/. Accessed 10 Oct 2014.
European Medicines Agency. Paediatric regulation. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000068.jsp. Accessed 10 Sept 2014.
US Food and Drug Administration. Should your child be in a clinical trial? http://www.fda.gov/forconsumers/consumerupdates/ucm048699.htm. Accessed 10 Sept 2014.
European Medicines Agency. Ethical considerations for clinical trials on medicinal products conducted with the paediatric population. http://ec.europa.eu/health/files/eudralex/vol-10/ethical_considerations_en.pdf. Accessed 10 Oct 2014.
European Medicines Agency. Medicines for children. http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000302.jsp. Accessed 10 Oct 2014.
Boots I, Sukhai RM, Klein RH, Holl RA, Wit JM, Cohen AF, et al. Stimulation programmes for pediatric drug research – do children really benefit? Eur J Pediatr. 2007;166:849–55. doi:10.1007/s00431-0016-0381-z.
World Health Organization. Essential medicines for children. Paediatric medicines Regulators’ Network (PmRN). http://www.who.int/childmedicines/paediatric_regulators/en/. Accessed 10 Oct 2014.
United Nations 2012. Every woman every child. UN Commission on life-saving commodities for women and children. Commissioners’ report, Sept 2012. http://everywomaneverychild.org/images/UN_Commission_Report_September_2012_Final.pdf. Accessed 8 Oct 2014.
International Union Against Tuberculosis and Lung Disease. Global asthma report 2011. http://www.globalasthmanetwork.org/publications/Global_Asthma_Report_2011.pdf. Accessed 6 Sept 2014.
World Health Organization. WHO essential medicines and health products information portal. http://apps.who.int/medicinedocs/en/. Accessed 10 Oct 2014.
Oxman AD, Glenton C, Lewin S, Olsen K, Rosenbaum SE, Austvoll-Dahlgren A. Supporting informed health choices in low income countries. http://www.kunnskapssenteret.no/prosjekter/sihclic?language=english. Accessed 6 Sept 2014.
World Health Organization. Service availability and readiness assessment. http://www.who.int/healthinfo/systems/sara_introduction/en/. Accessed 6 Sept 2014.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ondari, C., Hedman, L., Robertson, J. (2015). Children Everywhere Deserve Evidence-Based and Accessible Treatment. In: MacLeod, S., Hill, S., Koren, G., Rane, A. (eds) Optimizing Treatment for Children in the Developing World. Adis, Cham. https://doi.org/10.1007/978-3-319-15750-4_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-15750-4_1
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-15749-8
Online ISBN: 978-3-319-15750-4
eBook Packages: MedicineMedicine (R0)